These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3. Shi L; Wan Y; Sun G; Zhang S; Wang Z; Zeng Y BioDrugs; 2014 Feb; 28(1):41-54. PubMed ID: 23857508 [TBL] [Abstract][Full Text] [Related]
25. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism. Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852 [TBL] [Abstract][Full Text] [Related]
26. Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151. Tilghman J; Schiapparelli P; Lal B; Ying M; Quinones-Hinojosa A; Xia S; Laterra J Neoplasia; 2016 Mar; 18(3):185-98. PubMed ID: 26992919 [TBL] [Abstract][Full Text] [Related]
27. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
28. Melatonin Inhibits Glioblastoma Stem-like cells through Suppression of EZH2-NOTCH1 Signaling Axis. Zheng X; Pang B; Gu G; Gao T; Zhang R; Pang Q; Liu Q Int J Biol Sci; 2017; 13(2):245-253. PubMed ID: 28255276 [TBL] [Abstract][Full Text] [Related]
29. Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma. Wu M; Guan J; Li C; Gunter S; Nusrat L; Ng S; Dhand K; Morshead C; Kim A; Das S Oncotarget; 2017 Oct; 8(47):82217-82230. PubMed ID: 29137258 [TBL] [Abstract][Full Text] [Related]
30. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations. Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081 [TBL] [Abstract][Full Text] [Related]
31. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223 [TBL] [Abstract][Full Text] [Related]
32. Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome. Masliantsev K; Pinel B; Balbous A; Guichet PO; Tachon G; Milin S; Godet J; Duchesne M; Berger A; Petropoulos C; Wager M; Karayan-Tapon L Oncotarget; 2018 Jan; 9(3):3968-3979. PubMed ID: 29423098 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation. Shen L; Qin K; Wang D; Zhang Y; Bai N; Yang S; Luo Y; Xiang R; Tan X Biochim Biophys Acta; 2014 Nov; 1842(11):2087-95. PubMed ID: 25068817 [TBL] [Abstract][Full Text] [Related]
34. Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells. Marfia G; Campanella R; Navone SE; Di Vito C; Riccitelli E; Hadi LA; Bornati A; de Rezende G; Giussani P; Tringali C; Viani P; Rampini P; Alessandri G; Parati E; Riboni L Glia; 2014 Dec; 62(12):1968-81. PubMed ID: 25042636 [TBL] [Abstract][Full Text] [Related]
35. Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome. Marziali G; Signore M; Buccarelli M; Grande S; Palma A; Biffoni M; Rosi A; D'Alessandris QG; Martini M; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Sci Rep; 2016 Feb; 6():21557. PubMed ID: 26857460 [TBL] [Abstract][Full Text] [Related]
36. EGFR signaling is differentially activated in patient-derived glioblastoma stem cells. Howard BM; Gursel DB; Bleau AM; Beyene RT; Holland EC; Boockvar JA J Exp Ther Oncol; 2010; 8(3):247-60. PubMed ID: 20734923 [TBL] [Abstract][Full Text] [Related]
37. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma. Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521 [TBL] [Abstract][Full Text] [Related]
38. MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG. Shang C; Guo Y; Hong Y; Liu YH; Xue YX Mol Biol Rep; 2015 Mar; 42(3):721-7. PubMed ID: 25394756 [TBL] [Abstract][Full Text] [Related]
39. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis. Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407 [TBL] [Abstract][Full Text] [Related]
40. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide. Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]